About Divis Laboratories
Divis Laboratories is a company based in Hyderabad (India) founded in 1990 by Murali K Divi.. The company has 18,300 employees as of March 31, 2024. Divis Laboratories offers products and services including Naproxen, Dextromethorphan, Gabapentin, Beta Carotene, and Vitamin D3. Divis Laboratories operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Hyderabad, India
- Employees 18300 as on 31 Mar, 2024
- Founders Murali K Divi
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Divi's Laboratories Limited
-
Annual Revenue
$1.09 B (USD)19.48as on Mar 31, 2024
-
Net Profit
$255.96 M (USD)36.94as on Mar 31, 2024
-
EBITDA
$355.14 M (USD)30.47as on Mar 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
18300
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Divis Laboratories
Divis Laboratories is a publicly listed company on the NSE with ticker symbol DIVISLAB in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Divis Laboratories
Divis Laboratories offers a comprehensive portfolio of products and services, including Naproxen, Dextromethorphan, Gabapentin, Beta Carotene, and Vitamin D3. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Active ingredient for pain and inflammation relief medications
Cough suppressant used in respiratory treatments
Medication for nerve pain and seizures management
Antioxidant supplement for nutritional health
Essential vitamin for bone health and immunity
Unlock access to complete
Funding Insights of Divis Laboratories
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Divis Laboratories
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Divis Laboratories
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Divis Laboratories Comparisons
Competitors of Divis Laboratories
Divis Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical and biotechnology company
|
|
| domain | founded_year | HQ Location |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| domain | founded_year | HQ Location |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| domain | founded_year | HQ Location |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
APIs are developed and manufactured for therapeutic areas.
|
|
| domain | founded_year | HQ Location |
Contract development, manufacturing, and analytical services for APIs are offered.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Divis Laboratories
Frequently Asked Questions about Divis Laboratories
When was Divis Laboratories founded?
Divis Laboratories was founded in 1990.
Where is Divis Laboratories located?
Divis Laboratories is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
How many employees does Divis Laboratories have?
As of Mar 31, 2024, the latest employee count at Divis Laboratories is 18,300.
What is the annual revenue of Divis Laboratories?
Annual revenue of Divis Laboratories is $1.09B as on Mar 31, 2024.
What does Divis Laboratories do?
Divis Laboratories was founded in 1990 in Hyderabad, India, and operates as a contract manufacturer in the pharmaceutical sector. Synthesis of chiral compounds and protected amino acids is specialized in, along with custom services for APIs and advanced intermediates used in drug discovery. Alternate processes that avoid patent infringement are developed for APIs and intermediates. Operations focus on providing these services to support pharmaceutical development.
Who are the top competitors of Divis Laboratories?
Divis Laboratories's top competitors include Laurus Labs, Symbiotec and NGL Fine Chem.
What products or services does Divis Laboratories offer?
Divis Laboratories offers Naproxen, Dextromethorphan, Gabapentin, Beta Carotene, and Vitamin D3.
Is Divis Laboratories publicly traded?
Yes, Divis Laboratories is publicly traded on NSE under the ticker symbol DIVISLAB.
What is Divis Laboratories's ticker symbol?
The ticker symbol of Divis Laboratories is DIVISLAB on NSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.